Search

Search Constraints

You searched for: Author/Creator McGoldrick, Kelly

Search Results

2. Differences in patient ascertainment affect the use of gene‐specified ACMG/AMP phenotype‐related variant classification criteria: Evidence for TP53. Issue 3 (16th January 2020)

3. Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants. Issue 3 (25th December 2020)

4. Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines. Issue 9 (12th June 2020)